Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

2nd ADC Toxicity Summit

Evvnt Promotion / evvnt
-
23.07.2024 - 25.07.2024  Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 9:00 am to 5:00 pm
 
Temi della conferenza
Toxicities continue to pose the most significant challenge in the progression of antibody-drug conjugates to the clinic, and with increasing companies entering into the ADC space and tackling toxicity, there is ever-increasing target and indication-competition. Considering the significant clinical setbacks witnessed in 2023, the demand to better understand the translatability of toxicities and develop more tolerable ADCs for achieving future clinical triumphs only grows stronger.
Scientific organizer
Hanson Wade Group
Annotazioni
Brochure: https://go.evvnt.com/2381308-3?pid=4832

Speakers: Ali Warbington, Director, Toxicology, ImmunoGen, Arnima Bisht, Senior Director, Oxford BioTherapeutics and More.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/2381308-2?pid=4832
Mr. Luke Kelly
 
Categorie
Farmacologia e Tossicologia, Immunologia e Patologia
Lingua
Inglese
Quote del Congresso
FULL PACKAGE: Conference + Workshop Day - Drug Developer: USD 4197.00, Conference Only - Drug Developer: USD 2999.00, FULL PACKAGE: Conference + Workshop Day - Solution Provider: USD 5097.00, Conference Only - Solution Provider: USD 3699.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Swiss Tropical and Public Health InstituteCharité International AcademynewTreeAMREF - African Medical and Research FoundationCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÖsterreichisches Rotes KreuzÄrzte der WeltEuropean Health Forum Gastein